Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ: LGND · Real-Time Price · USD

232.32

-9.47 (-3.92%)

At close: Apr 28, 2026, 4:00 PM EDT

232.33

+0.01 (0.00%)

After-hours: Apr 28, 2026, 5:27 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Revenue from Intangible Royalty Assets	132.53M	95.33M
Revenue from Intangible Royalty Assets Growth	39.03%	13.61%
Income from Financial Royalty Assets	28.47M	13.44M
Income from Financial Royalty Assets Growth	111.75%	1181.60%
Royalties Revenue	161.00M	108.77M
Royalties Revenue Growth	48.02%	28.03%
Captisol Revenue	40.21M	30.88M
Captisol Revenue Growth	30.21%	8.85%
Contract Revenue and Income	66.87M	27.48M
Contract Revenue and Income Growth	143.38%	52.79%
Revenue (Total)	268.09M	167.13M
Revenue (Total) Growth	60.40%	27.28%

Updated Feb 26, 2026. Data Source: Fiscal.ai.